![Marc Dechamps](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Marc Dechamps is currently an Independent Director at OSE Immunotherapeutics SA. Previously, he worked as the Co-Managing Director at Delphi Genetics SA and as the Director & Head of Business Development at eTheRNA immunotherapies NV.
Posizioni attive di Marc Dechamps
Società | Posizione | Inizio |
---|---|---|
OSE IMMUNOTHERAPEUTICS | Direttore/Membro del Consiglio | 19/06/2024 |
Precedenti posizioni note di Marc Dechamps
Società | Posizione | Fine |
---|---|---|
Delphi Genetics SA
![]() Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Amministratore Delegato | 01/07/2017 |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OSE IMMUNOTHERAPEUTICS | Health Technology |
Aziende private | 2 |
---|---|
Delphi Genetics SA
![]() Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Marc Dechamps